Q9973 – Injection, epoetin beta, 1 microgram, (non-esrd use)
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ9973
- Long description
- Injection, epoetin beta, 1 microgram, (non-esrd use)
- Short description
- Epoetin beta non esrd
- Pricing indicator
57Other carrier priced- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J0888
- Added
- July 1, 2014
- Last change
- January 1, 2015 – No change
- Termination date
- December 31, 2014
Frequently asked questions
What is HCPCS code Q9973?
Q9973 is a HCPCS Level II code for injection, epoetin beta, 1 microgram, (non-esrd use). It was discontinued on December 31, 2014.
Does Medicare cover Q9973?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q9964 – High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9965 – Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
- Q9966 – Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
- Q9967 – Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968 – Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9969 – Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
- Q9970 – Injection, ferric carboxymaltose, 1mg
- Q9972 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- Q9974 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- Q9975 – Injection, factor viii fc fusion protein (recombinant), per iu
- Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
- Q9977 – Compounded drug, not otherwise classified
- Q9978 – Netupitant 300 mg and palonosetron 0.5 mg
- Q9979 – Injection, alemtuzumab, 1 mg
- Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
- Q9981 – Rolapitant, oral, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.